Guangwei Huang
Anshun, 561000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
PCSK9 inhibitor attenuates cardiac fibrosis in reperfusion injury rat by suppressing inflammatory response and TGF-β1/Smad3 pathway.
Journal: Biochemical pharmacology
Published: February 09, 2024
Characteristics, prognostic determinants of monocytes, macrophages and T cells in acute coronary syndrome: protocol for a multicenter, prospective cohort study.
Journal: BMC cardiovascular disorders
Published: February 23, 2023
Correlation of apolipoprotein A-I with T cell subsets and interferon-ү in coronary artery disease.
Journal: Immunity, inflammation and disease
Published: October 23, 2022
Effect on hypoxia/reoxygenation-induced cardiomyocyte injury and Pink1/Parkin pathway.
Journal: General physiology and biophysics
Published: June 25, 2022
PCSK9 Knockdown Can Improve Myocardial Ischemia/Reperfusion Injury by Inhibiting Autophagy.
Journal: Cardiovascular toxicology
Published: June 14, 2022
PCSK9 inhibition protects against myocardial ischemia-reperfusion injury via suppressing autophagy.
Journal: Microvascular research
Published: February 19, 2022
Downregulation of TIGIT Expression in FOXP3+Regulatory T Cells in Acute Coronary Syndrome.
Journal: Journal of inflammation research
Published: November 26, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026